Medicare beneficiaries face much higher drug costs as plans shift to coinsurance
According to new research from the USC Schaeffer Center for Health Policy and Economics, expected out of-pocket costs for commonly prescribed brand-name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs … Read More »